American Vietnamese Biotech, Inc.
HHNX:AMV1,300.00
VND
+100.00
(+8.33%)
ISIN
VN000000AMV5
Return %
Stock
S&P 500
1Y
-35.00
14.20
3Y
-64.86
81.12
5Y
-87.52
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Thi Nuong Dang
- Full Time Employees
- 103
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Ho Chi Minh City Vietnam
- IPO Date
- Dec 20, 2009
- Website
- amvibiotech.com
- Similar Companies
- Business
- American Vietnamese Biotech, Inc. (HNX: AMV) is a Vietnam-based healthcare and medical technology company primarily engaged in the manufacturing, importation, distribution, and maintenance of medical equipment, pharmaceuticals, and diagnostic reagents, as well as the operation of specialized clinical healthcare services. Founded in 2002 and headquartered in Hanoi, Vietnam, the company serves public and private hospitals, clinical laboratories, diagnostic centers, and healthcare institutions across nationwide markets. The company provides a comprehensive portfolio of healthcare products and services, including diagnostic imaging systems such as digital X-ray units, ultrasound machines, computed tomography scanners, and magnetic resonance imaging systems; in vitro diagnostics (IVD) and clinical laboratory solutions comprising automated biochemical analyzers, hematology instruments, immunological testing systems, and specialized laboratory reagents; medical consumables and disposable supplies, including blood collection tubes, rapid diagnostic test kits, surgical disposables, and personal protective equipment; pharmaceutical formulations and therapeutic products distributed to institutional healthcare facilities and retail pharmacies; healthcare facility operations encompassing public-private joint-venture management of automated clinical testing centers, high-tech diagnostic imaging units, and specialized hemodialysis treatment facilities; and technical lifecycle services, including installation, calibration, preventive maintenance, and repair of high-complexity medical apparatus. In recent strategic and operational developments, American Vietnamese Biotech, Inc. has accelerated the expansion of its healthcare socialization partnership model, investing in modern diagnostic laboratories and hemodialysis units within provincial public hospitals to increase recurring service revenue. Additionally, the company has expanded international supply partnerships with medical technology manufacturers across Asia, Europe, and the United States to introduce automated diagnostic platforms and molecular testing reagents to the domestic market, while executing internal corporate restructuring to streamline its distribution network and optimize capital allocation toward high-margin clinical services.